http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113121617-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d1b89d0afdf2843e796e6d23c89a51e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-16
filingDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c904c949191883fe9bdd025725f116c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d768734f3cb83d3a6ee9753c978b292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2d4b96d0269e2e73f095afb9095c487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daabbc58f7f486d066958fdcc8628fe8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150b16e972481abefef78709baa570cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13d4733b4c98c9accd84961651cf086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc50e1c2939eb7c5a46b71aacd93289e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_726df582c48a856b74e5e3476d17de8e
publicationDate 2021-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113121617-A
titleOfInvention Synthetic method and application of clindamycin phosphate
abstract The invention belongs to the field of drug synthesis and discloses a method for synthesizing clindamycin phosphate. The present invention is tert-butyl(2-chloro-1-(3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)carbamate It is first chlorinated with phosphorus trichloride, then esterified with phosphorus oxychloride, and finally subjected to a condensation reaction with 1-methyl-4-propylpyrrolidine-2-carboxylic acid to obtain clindamycin phosphate. The method for synthesizing clindamycin phosphate provided by the invention uses molecules with smaller molecular weights as raw materials, which reduces the difficulty of purifying the intermediate, improves the recovery rate of the intermediate and reduces the production cost. The invention also provides an application of the method for synthesizing clindamycin phosphate. The method is used for synthesizing clindamycin phosphate, and the obtained clindamycin phosphate is used for preparing clindamycin phosphate injection .
priorityDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6419944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450024817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420277569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21887872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447700863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451836944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416172369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448654791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20365722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452160370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453330028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9886157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724699

Total number of triples: 76.